Skip to main content
I

IMPEDIMED LIMITED — Investor Relations & Filings

Ticker · IPD ISIN · AU000000IPD8 LEI · 254900I3YH2IS1UEHJ67 ASX Manufacturing
Filings indexed 1,536 across all filing types
Latest filing 2024-10-17 Regulatory Filings
Country AU Australia
Listing ASX IPD

About IMPEDIMED LIMITED

https://www.impedimed.com

ImpediMed Limited is a medical technology company specializing in the development and commercialization of non-invasive devices utilizing bioimpedance spectroscopy (BIS) technology. The company's core focus is the early detection and management of secondary lymphedema in oncology patients, particularly those undergoing treatment for breast cancer. Its flagship product, the SOZO digital health platform, provides rapid and precise measurements of extracellular fluid, total body water, and body composition. Beyond oncology, the technology is applied to the clinical monitoring of chronic heart failure and other conditions characterized by fluid imbalance. By delivering actionable data through its BIS technology, ImpediMed enables clinicians to implement early interventions and personalized care strategies. The platform is designed for seamless integration into clinical workflows to support longitudinal patient assessment.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting and Voting Form 29 pages 1.0MB
Regulatory Filings
2024-10-17 English
Virtual Meeting Online Guide 6 pages 2.1MB
Regulatory Filings
2024-10-17 English
Notification regarding unquoted securities - IPD 6 pages 18.9KB
Regulatory Filings
2024-10-15 English
Notification regarding unquoted securities - IPD 8 pages 24.6KB
Regulatory Filings
2024-10-15 English
Re-appointment of Non-Executive Director 1 page 302
Regulatory Filings
2024-10-14 English
Notification of Quarterly Results & Investor Conference Call 1
Regulatory Filings
2024-10-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.